FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $22,000 | -76.8% | 3,068 | -79.8% | 0.00% | – |
| Q1 2021 | $95,000 | -22.8% | 15,201 | -8.0% | 0.00% | – |
| Q4 2020 | $123,000 | +66.2% | 16,527 | +35.2% | 0.00% | – |
| Q3 2020 | $74,000 | -20.4% | 12,225 | +9.4% | 0.00% | – |
| Q2 2020 | $93,000 | +933.3% | 11,174 | +702.2% | 0.00% | – |
| Q4 2019 | $9,000 | -18.2% | 1,393 | -50.4% | 0.00% | – |
| Q2 2019 | $11,000 | -95.0% | 2,810 | -93.9% | 0.00% | – |
| Q1 2019 | $222,000 | +133.7% | 46,141 | +206.2% | 0.00% | – |
| Q4 2018 | $95,000 | -76.5% | 15,068 | -69.6% | 0.00% | – |
| Q3 2018 | $405,000 | -30.3% | 49,512 | -11.3% | 0.00% | – |
| Q2 2018 | $581,000 | +67.0% | 55,813 | +93.7% | 0.00% | – |
| Q1 2018 | $348,000 | +5700.0% | 28,811 | +4670.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 604 | +11980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |